Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neutrophils | 22 | 2024 | 3786 | 3.320 |
Why?
|
Candidiasis | 11 | 2024 | 367 | 3.090 |
Why?
|
Candida albicans | 21 | 2024 | 375 | 3.000 |
Why?
|
Antifungal Agents | 10 | 2024 | 761 | 2.420 |
Why?
|
Candida glabrata | 4 | 2024 | 38 | 2.170 |
Why?
|
Candida | 8 | 2023 | 173 | 2.100 |
Why?
|
Cryptococcus neoformans | 10 | 2020 | 121 | 2.030 |
Why?
|
Echinocandins | 5 | 2024 | 54 | 1.370 |
Why?
|
Lectins, C-Type | 12 | 2023 | 594 | 1.140 |
Why?
|
Aspergillus fumigatus | 9 | 2024 | 158 | 1.120 |
Why?
|
Cryptococcosis | 7 | 2020 | 103 | 1.120 |
Why?
|
Immunocompromised Host | 4 | 2020 | 863 | 1.010 |
Why?
|
Mycoses | 4 | 2021 | 386 | 0.980 |
Why?
|
Phagosomes | 6 | 2019 | 198 | 0.950 |
Why?
|
Cations | 1 | 2024 | 240 | 0.890 |
Why?
|
Phagocytosis | 12 | 2024 | 1530 | 0.890 |
Why?
|
Cytokines | 13 | 2024 | 7453 | 0.880 |
Why?
|
Aspergillosis | 6 | 2024 | 242 | 0.830 |
Why?
|
Hepatitis, Alcoholic | 1 | 2023 | 110 | 0.770 |
Why?
|
Biguanides | 2 | 2018 | 21 | 0.760 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2024 | 892 | 0.730 |
Why?
|
Macrophages | 13 | 2019 | 5799 | 0.720 |
Why?
|
Phagocytes | 2 | 2018 | 294 | 0.710 |
Why?
|
Drug Resistance, Fungal | 5 | 2024 | 78 | 0.690 |
Why?
|
Reactive Oxygen Species | 10 | 2024 | 2149 | 0.690 |
Why?
|
Blastomycosis | 2 | 2018 | 14 | 0.670 |
Why?
|
beta-Glucans | 5 | 2018 | 129 | 0.670 |
Why?
|
Malacoplakia | 1 | 2019 | 15 | 0.650 |
Why?
|
Toll-Like Receptors | 2 | 2022 | 582 | 0.620 |
Why?
|
Arthritis, Infectious | 1 | 2022 | 348 | 0.620 |
Why?
|
Antigens, Fungal | 6 | 2006 | 69 | 0.620 |
Why?
|
Diabetic Foot | 1 | 2022 | 382 | 0.600 |
Why?
|
Osteomyelitis | 1 | 2022 | 408 | 0.600 |
Why?
|
Exanthema | 1 | 2023 | 503 | 0.600 |
Why?
|
Immunity, Innate | 7 | 2024 | 3080 | 0.600 |
Why?
|
Polymers | 1 | 2024 | 1630 | 0.560 |
Why?
|
Blastomyces | 2 | 2018 | 10 | 0.560 |
Why?
|
Fungi | 5 | 2021 | 345 | 0.550 |
Why?
|
Respiratory Insufficiency | 3 | 2023 | 1240 | 0.550 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.540 |
Why?
|
Subclavian Artery | 1 | 2017 | 138 | 0.530 |
Why?
|
Takayasu Arteritis | 1 | 2017 | 106 | 0.510 |
Why?
|
Liver Diseases | 1 | 2023 | 1305 | 0.480 |
Why?
|
Enterobacteriaceae | 1 | 2016 | 161 | 0.470 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.470 |
Why?
|
Enterobacteriaceae Infections | 1 | 2016 | 190 | 0.450 |
Why?
|
Toll-Like Receptor 9 | 4 | 2019 | 199 | 0.450 |
Why?
|
Sepsis | 4 | 2022 | 2608 | 0.450 |
Why?
|
Abdominal Pain | 1 | 2020 | 1070 | 0.450 |
Why?
|
Microbial Sensitivity Tests | 5 | 2024 | 1967 | 0.440 |
Why?
|
Bacterial Infections | 1 | 2022 | 1397 | 0.430 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.420 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 744 | 0.420 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1596 | 0.420 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1960 | 0.410 |
Why?
|
Candidemia | 2 | 2023 | 40 | 0.400 |
Why?
|
Liver Transplantation | 1 | 2023 | 2401 | 0.370 |
Why?
|
Organ Transplantation | 1 | 2021 | 1176 | 0.370 |
Why?
|
Antigen Presentation | 4 | 2018 | 1251 | 0.360 |
Why?
|
Communicable Diseases | 2 | 2016 | 874 | 0.360 |
Why?
|
Cell Division | 1 | 2018 | 4473 | 0.360 |
Why?
|
Host-Pathogen Interactions | 4 | 2018 | 1469 | 0.350 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1437 | 0.350 |
Why?
|
Lung Transplantation | 2 | 2019 | 1309 | 0.340 |
Why?
|
Mice | 38 | 2024 | 82029 | 0.340 |
Why?
|
Kangai-1 Protein | 2 | 2019 | 22 | 0.330 |
Why?
|
Hyphae | 4 | 2022 | 52 | 0.330 |
Why?
|
Amphotericin B | 2 | 2021 | 143 | 0.320 |
Why?
|
Fatal Outcome | 5 | 2022 | 1836 | 0.310 |
Why?
|
Dendritic Cells | 5 | 2018 | 2747 | 0.310 |
Why?
|
Animals | 42 | 2024 | 169246 | 0.290 |
Why?
|
Signal Transduction | 11 | 2024 | 23645 | 0.280 |
Why?
|
Mannose-Binding Lectins | 3 | 2006 | 101 | 0.270 |
Why?
|
Bacteremia | 3 | 2024 | 986 | 0.270 |
Why?
|
Receptors, Mitogen | 1 | 2006 | 61 | 0.260 |
Why?
|
Fungal Proteins | 4 | 2023 | 906 | 0.260 |
Why?
|
Humans | 67 | 2024 | 768166 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2024 | 4352 | 0.250 |
Why?
|
Coronavirus, Bovine | 1 | 2024 | 2 | 0.240 |
Why?
|
Pneumonia | 2 | 2020 | 2163 | 0.240 |
Why?
|
Heart Transplantation | 1 | 2019 | 3301 | 0.240 |
Why?
|
Fomites | 1 | 2024 | 15 | 0.240 |
Why?
|
Textiles | 1 | 2024 | 44 | 0.240 |
Why?
|
Fluconazole | 3 | 2023 | 156 | 0.230 |
Why?
|
Monocytes | 4 | 2023 | 2605 | 0.230 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2024 | 133 | 0.230 |
Why?
|
Mannans | 2 | 2023 | 58 | 0.220 |
Why?
|
Leukocyte Elastase | 1 | 2024 | 114 | 0.220 |
Why?
|
Vimentin | 1 | 2024 | 257 | 0.220 |
Why?
|
Iron Chelating Agents | 1 | 2024 | 141 | 0.220 |
Why?
|
Cell Line | 11 | 2020 | 15597 | 0.220 |
Why?
|
Lung Diseases, Fungal | 3 | 2020 | 124 | 0.210 |
Why?
|
Feces | 3 | 2020 | 1511 | 0.210 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2023 | 631 | 0.210 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11928 | 0.210 |
Why?
|
Gram-Negative Bacteria | 1 | 2024 | 275 | 0.200 |
Why?
|
Leukocyte Transfusion | 1 | 2022 | 56 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 3 | 2021 | 3409 | 0.200 |
Why?
|
Lung | 6 | 2024 | 10099 | 0.190 |
Why?
|
Glycoconjugates | 1 | 2002 | 88 | 0.190 |
Why?
|
Aerosols | 1 | 2024 | 634 | 0.190 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2022 | 56 | 0.190 |
Why?
|
Pulmonary Aspergillosis | 1 | 2022 | 48 | 0.190 |
Why?
|
Granulocytes | 1 | 2023 | 551 | 0.190 |
Why?
|
Streptococcus pneumoniae | 2 | 2024 | 764 | 0.190 |
Why?
|
Glycoproteins | 2 | 2006 | 2202 | 0.180 |
Why?
|
Cell Degranulation | 1 | 2022 | 277 | 0.180 |
Why?
|
Mitochondria | 2 | 2024 | 3681 | 0.180 |
Why?
|
Mucormycosis | 1 | 2022 | 102 | 0.180 |
Why?
|
Flow Cytometry | 4 | 2023 | 5902 | 0.170 |
Why?
|
Histoplasma | 1 | 2020 | 40 | 0.170 |
Why?
|
Receptors, Cell Surface | 4 | 2006 | 2819 | 0.170 |
Why?
|
Travel | 2 | 2017 | 805 | 0.170 |
Why?
|
Histoplasmosis | 1 | 2020 | 63 | 0.170 |
Why?
|
NF-kappa B | 3 | 2024 | 2493 | 0.170 |
Why?
|
Interferon Type I | 1 | 2024 | 569 | 0.170 |
Why?
|
Membrane Glycoproteins | 4 | 2004 | 3711 | 0.170 |
Why?
|
Cytodiagnosis | 1 | 2023 | 452 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Transplants | 1 | 2021 | 208 | 0.160 |
Why?
|
Economics, Medical | 1 | 2019 | 112 | 0.160 |
Why?
|
Wuchereria bancrofti | 1 | 2018 | 20 | 0.160 |
Why?
|
Brugia | 1 | 2018 | 24 | 0.160 |
Why?
|
Cattle | 1 | 2024 | 3819 | 0.160 |
Why?
|
Bone Marrow Cells | 3 | 2021 | 2414 | 0.150 |
Why?
|
Adenine | 1 | 2024 | 995 | 0.150 |
Why?
|
Elephantiasis, Filarial | 1 | 2018 | 31 | 0.150 |
Why?
|
Hybrid Cells | 1 | 2018 | 421 | 0.150 |
Why?
|
beta-Lactamases | 2 | 2019 | 307 | 0.150 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2019 | 705 | 0.150 |
Why?
|
Calcitonin | 1 | 2019 | 328 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2020 | 175 | 0.150 |
Why?
|
Lipopeptides | 1 | 2018 | 71 | 0.140 |
Why?
|
Biofilms | 2 | 2019 | 634 | 0.140 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.140 |
Why?
|
Macrophages, Peritoneal | 1 | 2018 | 244 | 0.140 |
Why?
|
Cell Tracking | 1 | 2018 | 140 | 0.140 |
Why?
|
Thrombocytosis | 1 | 2017 | 88 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2021 | 610 | 0.140 |
Why?
|
Ribosome Inactivating Proteins, Type 1 | 1 | 2016 | 28 | 0.130 |
Why?
|
Ascomycota | 1 | 2017 | 81 | 0.130 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22379 | 0.130 |
Why?
|
Male | 24 | 2024 | 364719 | 0.130 |
Why?
|
Eye Infections, Bacterial | 1 | 2019 | 239 | 0.130 |
Why?
|
Protein Kinase C-delta | 1 | 2016 | 115 | 0.130 |
Why?
|
Erythema | 1 | 2017 | 261 | 0.130 |
Why?
|
Piperidines | 1 | 2024 | 1667 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13014 | 0.120 |
Why?
|
T-Lymphocytes | 6 | 2011 | 10266 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2019 | 5717 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2019 | 725 | 0.120 |
Why?
|
Models, Economic | 1 | 2019 | 719 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2024 | 1761 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 623 | 0.110 |
Why?
|
Glucocorticoids | 2 | 2020 | 2167 | 0.110 |
Why?
|
Infratentorial Neoplasms | 1 | 2015 | 99 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2018 | 2474 | 0.110 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 3049 | 0.110 |
Why?
|
Kidney Tubules | 1 | 2015 | 454 | 0.110 |
Why?
|
Nitriles | 1 | 2019 | 980 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 589 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7477 | 0.110 |
Why?
|
Neck | 1 | 2018 | 736 | 0.110 |
Why?
|
Middle Aged | 13 | 2024 | 223492 | 0.110 |
Why?
|
Case-Control Studies | 2 | 2022 | 22291 | 0.110 |
Why?
|
Triazoles | 1 | 2019 | 904 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1667 | 0.110 |
Why?
|
Bacteria | 1 | 2024 | 2216 | 0.110 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2013 | 47 | 0.110 |
Why?
|
CARD Signaling Adaptor Proteins | 3 | 2024 | 165 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3348 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3238 | 0.100 |
Why?
|
Female | 19 | 2024 | 397192 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1900 | 0.100 |
Why?
|
Catalase | 2 | 2022 | 215 | 0.100 |
Why?
|
Saccharomyces cerevisiae | 3 | 2011 | 2682 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1242 | 0.100 |
Why?
|
Boston | 2 | 2022 | 9374 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2021 | 3073 | 0.100 |
Why?
|
Cell Wall | 3 | 2017 | 421 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 467 | 0.090 |
Why?
|
Community-Acquired Infections | 1 | 2015 | 472 | 0.090 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2024 | 175 | 0.090 |
Why?
|
Drug Combinations | 1 | 2018 | 2089 | 0.090 |
Why?
|
Melanoma | 2 | 2020 | 5706 | 0.090 |
Why?
|
Vitamin A | 1 | 2014 | 611 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1014 | 0.090 |
Why?
|
Cornea | 1 | 2019 | 1316 | 0.090 |
Why?
|
Necrosis | 1 | 2015 | 1616 | 0.090 |
Why?
|
Aged | 11 | 2024 | 171504 | 0.090 |
Why?
|
Immunoconjugates | 1 | 2019 | 975 | 0.090 |
Why?
|
Optical Tweezers | 1 | 2011 | 83 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2019 | 1276 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2885 | 0.090 |
Why?
|
Macrophages, Alveolar | 1 | 2013 | 415 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1429 | 0.090 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2006 | 827 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2016 | 2433 | 0.090 |
Why?
|
Astrocytoma | 1 | 2015 | 774 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1512 | 0.090 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 235 | 0.090 |
Why?
|
Metformin | 1 | 2018 | 909 | 0.080 |
Why?
|
Virulence | 2 | 2011 | 1297 | 0.080 |
Why?
|
Fungal Vaccines | 3 | 2004 | 7 | 0.080 |
Why?
|
Cell Membrane | 1 | 2019 | 3655 | 0.080 |
Why?
|
Bronchoscopy | 1 | 2015 | 914 | 0.080 |
Why?
|
Medulloblastoma | 1 | 2015 | 683 | 0.080 |
Why?
|
Influenza, Human | 1 | 2021 | 1541 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2892 | 0.080 |
Why?
|
Nervous System Malformations | 1 | 2011 | 243 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 330 | 0.080 |
Why?
|
Inflammation | 4 | 2024 | 10873 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20760 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1074 | 0.080 |
Why?
|
Receptors, Immunologic | 2 | 2005 | 1418 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2062 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2211 | 0.080 |
Why?
|
Microscopy, Confocal | 2 | 2011 | 1972 | 0.080 |
Why?
|
Escherichia coli | 2 | 2019 | 4214 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1085 | 0.080 |
Why?
|
Polysaccharides | 2 | 2005 | 1024 | 0.070 |
Why?
|
Fever | 1 | 2015 | 1614 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1883 | 0.070 |
Why?
|
Immunotherapy | 2 | 2020 | 4755 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1514 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 747 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2013 | 3590 | 0.070 |
Why?
|
Pyridines | 1 | 2019 | 2894 | 0.070 |
Why?
|
Hybridomas | 3 | 2002 | 444 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5349 | 0.070 |
Why?
|
DNA Damage | 1 | 2016 | 2469 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2014 | 1596 | 0.060 |
Why?
|
Mice, Knockout | 6 | 2019 | 14488 | 0.060 |
Why?
|
Bacterial Capsules | 1 | 2005 | 247 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3706 | 0.060 |
Why?
|
Rotenone | 1 | 2024 | 50 | 0.060 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2024 | 64 | 0.060 |
Why?
|
Streptolysins | 1 | 2024 | 61 | 0.060 |
Why?
|
Radiography | 1 | 2015 | 6983 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2005 | 1754 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1892 | 0.060 |
Why?
|
K562 Cells | 1 | 2006 | 644 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10399 | 0.060 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2024 | 82 | 0.060 |
Why?
|
Chemotactic Factors | 1 | 2024 | 197 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2022 | 59629 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2016 | 2486 | 0.050 |
Why?
|
Headache | 1 | 2011 | 1263 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2057 | 0.050 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 112 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2022 | 2059 | 0.050 |
Why?
|
Hospitalization | 2 | 2021 | 10840 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2024 | 11669 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Carbohydrate Conformation | 1 | 2002 | 206 | 0.050 |
Why?
|
Adult | 7 | 2024 | 223646 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 242 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2024 | 393 | 0.050 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 921 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 318 | 0.050 |
Why?
|
Ergosterol | 1 | 2021 | 19 | 0.050 |
Why?
|
Interleukin-1beta | 2 | 2019 | 1027 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 3980 | 0.040 |
Why?
|
Superinfection | 1 | 2021 | 62 | 0.040 |
Why?
|
Lipogenesis | 1 | 2022 | 217 | 0.040 |
Why?
|
Amidohydrolases | 1 | 2001 | 160 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5863 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4598 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2020 | 93 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Bone Marrow | 2 | 2021 | 2935 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11519 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 839 | 0.040 |
Why?
|
CHO Cells | 1 | 2002 | 1379 | 0.040 |
Why?
|
Inflammasomes | 1 | 2024 | 540 | 0.040 |
Why?
|
Organ Specificity | 1 | 2004 | 1968 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11878 | 0.040 |
Why?
|
Acute Disease | 2 | 2024 | 7243 | 0.040 |
Why?
|
Spectrum Analysis, Raman | 1 | 2021 | 253 | 0.040 |
Why?
|
Capsules | 1 | 2019 | 193 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2019 | 144 | 0.040 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2018 | 14 | 0.040 |
Why?
|
Cricetinae | 1 | 2002 | 2423 | 0.040 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2002 | 549 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5953 | 0.040 |
Why?
|
Membrane Microdomains | 1 | 2019 | 205 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5703 | 0.040 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2019 | 432 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8741 | 0.040 |
Why?
|
Immunological Synapses | 1 | 2018 | 58 | 0.040 |
Why?
|
Perforin | 1 | 2018 | 167 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2002 | 1441 | 0.040 |
Why?
|
Nitrous Oxide | 1 | 2018 | 166 | 0.040 |
Why?
|
Microbial Viability | 1 | 2018 | 237 | 0.040 |
Why?
|
Microscopy, Atomic Force | 1 | 2018 | 250 | 0.040 |
Why?
|
Biopsy | 2 | 2020 | 6793 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2020 | 753 | 0.030 |
Why?
|
Spleen | 2 | 2018 | 2295 | 0.030 |
Why?
|
Vaccines | 1 | 2005 | 842 | 0.030 |
Why?
|
Spores, Fungal | 1 | 2017 | 90 | 0.030 |
Why?
|
Peroxidase | 1 | 2020 | 610 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 60066 | 0.030 |
Why?
|
Jejunum | 1 | 2019 | 475 | 0.030 |
Why?
|
Immunogenetic Phenomena | 1 | 2016 | 23 | 0.030 |
Why?
|
Microfluidics | 1 | 2022 | 672 | 0.030 |
Why?
|
Genetic Enhancement | 1 | 2016 | 18 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 81762 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2018 | 944 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2016 | 19015 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1083 | 0.030 |
Why?
|
Cough | 1 | 2020 | 598 | 0.030 |
Why?
|
Ion Channels | 1 | 2021 | 1043 | 0.030 |
Why?
|
Immunotoxins | 1 | 2016 | 175 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 772 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2018 | 825 | 0.030 |
Why?
|
Dermatitis, Contact | 1 | 1996 | 134 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9561 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2024 | 3703 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2018 | 574 | 0.030 |
Why?
|
Extremities | 1 | 2021 | 870 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 1839 | 0.030 |
Why?
|
Macrophage-1 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 36743 | 0.030 |
Why?
|
Hypersensitivity, Delayed | 1 | 1996 | 491 | 0.030 |
Why?
|
Carbohydrates | 1 | 2017 | 389 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2024 | 65371 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18349 | 0.030 |
Why?
|
Cell Polarity | 1 | 2018 | 639 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2415 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1760 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2661 | 0.030 |
Why?
|
Shock, Septic | 1 | 2021 | 774 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1353 | 0.030 |
Why?
|
Cell Movement | 2 | 2024 | 5210 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2028 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1320 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 1996 | 605 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1679 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16726 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1338 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2018 | 6514 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 1133 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1321 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 199 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 13490 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.030 |
Why?
|
Zymosan | 1 | 2013 | 134 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 742 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6961 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 806 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 964 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2019 | 802 | 0.030 |
Why?
|
Cellulases | 1 | 2011 | 10 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1063 | 0.020 |
Why?
|
Models, Animal | 1 | 2018 | 2120 | 0.020 |
Why?
|
Dyspnea | 1 | 2020 | 1352 | 0.020 |
Why?
|
Career Choice | 1 | 2018 | 769 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 840 | 0.020 |
Why?
|
Colon | 1 | 2020 | 1801 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2014 | 557 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3840 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5505 | 0.020 |
Why?
|
Proteoglycans | 1 | 2014 | 809 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3284 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2709 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 30010 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2004 | 4793 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Tension-Type Headache | 1 | 2011 | 76 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 30238 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1951 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2981 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2010 | 140 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 687 | 0.020 |
Why?
|
HIV Antigens | 1 | 2010 | 328 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3833 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2002 | 4415 | 0.020 |
Why?
|
Brain | 2 | 2020 | 27360 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1399 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13671 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 17140 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2381 | 0.020 |
Why?
|
HIV Infections | 2 | 2018 | 17569 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2732 | 0.020 |
Why?
|
Surface Properties | 1 | 2011 | 1166 | 0.020 |
Why?
|
Models, Biological | 2 | 2016 | 9495 | 0.020 |
Why?
|
Infant | 3 | 2018 | 36535 | 0.020 |
Why?
|
Microspheres | 1 | 2011 | 788 | 0.020 |
Why?
|
Lysosomes | 1 | 2014 | 938 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1907 | 0.020 |
Why?
|
Social Behavior | 1 | 2015 | 1147 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1996 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42669 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1886 | 0.020 |
Why?
|
Antibodies | 1 | 1996 | 2421 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12077 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2515 | 0.020 |
Why?
|
United States | 3 | 2021 | 73039 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10632 | 0.020 |
Why?
|
Alleles | 2 | 2010 | 6894 | 0.020 |
Why?
|
Thrombosis | 1 | 2021 | 2957 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3474 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2298 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2002 | 4168 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12465 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5777 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10590 | 0.020 |
Why?
|
Pichia | 1 | 2005 | 49 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16045 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13586 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10101 | 0.020 |
Why?
|
Chitin | 1 | 2004 | 34 | 0.020 |
Why?
|
Gene Expression | 2 | 2011 | 7598 | 0.010 |
Why?
|
Glucosyltransferases | 1 | 2004 | 94 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2633 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18065 | 0.010 |
Why?
|
Amino Acids | 1 | 2010 | 1716 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2722 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3228 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 2004 | 557 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18412 | 0.010 |
Why?
|
Ovalbumin | 1 | 2005 | 677 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74944 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2004 | 915 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9015 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9384 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3956 | 0.010 |
Why?
|
Kidney | 1 | 2018 | 7064 | 0.010 |
Why?
|
Oligosaccharides | 1 | 2004 | 407 | 0.010 |
Why?
|
Child | 3 | 2018 | 80917 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8080 | 0.010 |
Why?
|
Adolescent | 3 | 2018 | 89169 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1683 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21538 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2004 | 348 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 7140 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9419 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5432 | 0.010 |
Why?
|
DNA, Fungal | 1 | 2002 | 275 | 0.010 |
Why?
|
Viral Load | 1 | 2010 | 3396 | 0.010 |
Why?
|
Genes, Fungal | 1 | 2002 | 440 | 0.010 |
Why?
|
Base Sequence | 2 | 2002 | 12421 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 588 | 0.010 |
Why?
|
Hypertension | 1 | 2021 | 8616 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5403 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13421 | 0.010 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2004 | 582 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1779 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9538 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 17622 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9263 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2173 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2011 | 1713 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9118 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5027 | 0.010 |
Why?
|
Temperature | 1 | 2004 | 2234 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26422 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2748 | 0.010 |
Why?
|
Gene Deletion | 1 | 2004 | 2675 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2828 | 0.010 |
Why?
|
Phylogeny | 1 | 2004 | 2843 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2010 | 4648 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13290 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6231 | 0.010 |
Why?
|
Models, Genetic | 1 | 2004 | 3447 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1996 | 1162 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 2909 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1996 | 2300 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12795 | 0.010 |
Why?
|
Liver | 1 | 2005 | 7577 | 0.010 |
Why?
|
Neoplasms | 1 | 2019 | 22371 | 0.010 |
Why?
|
Rabbits | 1 | 1996 | 4772 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14729 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2004 | 10474 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 41754 | 0.000 |
Why?
|
Time Factors | 1 | 2004 | 40218 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23760 | 0.000 |
Why?
|